Saffron for mild cognitive impairment and dementia: a systematic review and meta-analysis of randomised clinical trials.

BMC Complement Med Ther · 2020 · PMC7650148 · PMID 33167948

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

failed to reach statistical significanceno p-value reported

An improvement in Montreal Cognitive Assessment (MoCA) score was also observed in the saffron group compare to “no treatment” but the changes in MMSE and MoCA failed to reach statistical significance (Table 2 ).

also in 6,035 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.